243 related articles for article (PubMed ID: 483248)
1. Factor XII-dependent fibrinolysis: a double function of plasma kallikrein and the occurrence of a previously undescribed factor XII- and kallikrein-dependent plasminogen proactivator.
Kluft C; Trumpi-Kalshoven MM; Jie AF; Veldhuyzen-Stolk EC
Thromb Haemost; 1979 Jun; 41(4):756-73. PubMed ID: 483248
[TBL] [Abstract][Full Text] [Related]
2. Factor XII-induced fibrinolysis. Diminished proactivator activity and drastic reduction of activator activity in Fletcher factor-deficient plasma gamma globulin.
Espana F; Aznar J; Estelles A
J Lab Clin Med; 1982 Nov; 100(5):756-70. PubMed ID: 6182261
[TBL] [Abstract][Full Text] [Related]
3. An analysis of the activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction of normal plasma and of plasmas deficient in factor XII and prekallikrein.
Binnema DJ; Dooijewaard G; Turion PN
Thromb Haemost; 1991 Feb; 65(2):144-8. PubMed ID: 1905069
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of factor XII-dependent plasminogen proactivator in prekallikrein-deficient plasma.
Bouma BN; Griffin JH
J Lab Clin Med; 1978 Jan; 91(1):148-55. PubMed ID: 73563
[TBL] [Abstract][Full Text] [Related]
5. Fibrinolytic studies in 13 unrelated families with factor XII deficiency.
Rodeghiero F; Castaman G; Ruggeri M; Cazzavillan M; Ferracin G; Dini E
Haematologica; 1991; 76(1):28-32. PubMed ID: 2055558
[TBL] [Abstract][Full Text] [Related]
6. Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways.
Colman RW; Bagdasarian A; Talamo RC; Scott CF; Seavey M; Guimaraes JA; Pierce JV; Kaplan AP
J Clin Invest; 1975 Dec; 56(6):1650-62. PubMed ID: 1202089
[TBL] [Abstract][Full Text] [Related]
7. [Plasma kallikrein: new functions].
Paskhina TS
Biokhimiia; 1976 Aug; 41(8):1347-51. PubMed ID: 1030643
[TBL] [Abstract][Full Text] [Related]
8. Intrinsic plasma fibrinolysis: involvement of urokinase-related activity in the factor XII-independent plasminogen proactivator pathway.
Kluft C; Wijngaards G; Jie AF
J Lab Clin Med; 1984 Mar; 103(3):408-19. PubMed ID: 6199446
[TBL] [Abstract][Full Text] [Related]
9. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
Weiss AS; Gallin JI; Kaplan AP
J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
[TBL] [Abstract][Full Text] [Related]
10. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.
Saito H; Ratnoff OD
J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996
[TBL] [Abstract][Full Text] [Related]
11. Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo.
Levi M; Hack CE; de Boer JP; Brandjes DP; Büller HR; ten Cate JW
J Clin Invest; 1991 Oct; 88(4):1155-60. PubMed ID: 1833421
[TBL] [Abstract][Full Text] [Related]
12. Activation of human factor VII in plasma and in purified systems: roles of activated factor IX, kallikrein, and activated factor XII.
Seligsohn U; Osterud B; Brown SF; Griffin JH; Rapaport SI
J Clin Invest; 1979 Oct; 64(4):1056-65. PubMed ID: 479368
[TBL] [Abstract][Full Text] [Related]
13. Immunochemical studies of plasma kallikrein.
Bagdasarian A; Lahiri B; Talamo RC; Wong P; Colman RW
J Clin Invest; 1974 Dec; 54(6):1444-54. PubMed ID: 4140197
[TBL] [Abstract][Full Text] [Related]
14. [Contact activation of prekallikrein and plasminogen in plasma].
Veremeenko KN; Volokhonskaia LI; Kizim AI; Pogorelaia NF
Ukr Biokhim Zh (1978); 1983; 55(3):295-301. PubMed ID: 6553425
[TBL] [Abstract][Full Text] [Related]
15. The role of HF cofactor in the Hageman factor-dependent fibrinolytic mechanism.
Iatridis PG; Gadarowski JJ; Iatridis SG
Acta Haematol; 1981; 66(4):257-63. PubMed ID: 6800192
[TBL] [Abstract][Full Text] [Related]
16. Increased euglobulin fibrinolytic potential in women on oral contraceptives low in oestrogen--levels of extrinsic and intrinsic plasminogen activators, prekallikrein, factor XII, and C1-inactivator.
Jespersen J; Kluft C
Thromb Haemost; 1985 Aug; 54(2):454-9. PubMed ID: 2417350
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitro.
Tanaka A; Suzuki Y; Sugihara K; Kanayama N; Urano T
Life Sci; 2009 Jul; 85(5-6):220-5. PubMed ID: 19500599
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activators in dextran sulfate-activated euglobulin fractions: a molecular analysis of factor XII- and prekallikrein-dependent fibrinolysis.
Hauert J; Nicoloso G; Schleuning WD; Bachmann F; Schapira M
Blood; 1989 Mar; 73(4):994-9. PubMed ID: 2465792
[TBL] [Abstract][Full Text] [Related]
19. Analysis of intrinsic fibrinolysis in human plasma induced by dextran sulfate.
Tsuda H; Miyata T; Iwanaga S; Yamamoto T
Thromb Haemost; 1992 Apr; 67(4):440-4. PubMed ID: 1631792
[TBL] [Abstract][Full Text] [Related]
20. Hageman-factor-dependent fibrinolysis: generation of fibrinolytic activity by the interaction of human activated factor XI and plasminogen.
Mandle RJ; Kaplan AP
Blood; 1979 Oct; 54(4):850-62. PubMed ID: 89876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
